Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AZACITIDINE Cause Electrocardiogram qt prolonged? 47 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 47 reports of Electrocardiogram qt prolonged have been filed in association with AZACITIDINE (Azacitidine). This represents 0.2% of all adverse event reports for AZACITIDINE.

47
Reports of Electrocardiogram qt prolonged with AZACITIDINE
0.2%
of all AZACITIDINE reports
15
Deaths
23
Hospitalizations

How Dangerous Is Electrocardiogram qt prolonged From AZACITIDINE?

Of the 47 reports, 15 (31.9%) resulted in death, 23 (48.9%) required hospitalization, and 3 (6.4%) were considered life-threatening.

Is Electrocardiogram qt prolonged Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AZACITIDINE. However, 47 reports have been filed with the FAERS database.

What Other Side Effects Does AZACITIDINE Cause?

Febrile neutropenia (2,172) Death (1,853) Pneumonia (1,315) Neutropenia (1,176) Acute myeloid leukaemia (1,156) Off label use (1,064) Pyrexia (1,011) Thrombocytopenia (968) Myelosuppression (952) Anaemia (857)

What Other Drugs Cause Electrocardiogram qt prolonged?

QUETIAPINE (1,869) OLANZAPINE (1,325) RIBOCICLIB (1,020) AMIODARONE (1,000) HYDROXYCHLOROQUINE (992) CLOZAPINE (958) CITALOPRAM HYDROBROMIDE (917) ESCITALOPRAM OXALATE (899) ONDANSETRON (881) BUPROPION (853)

Which AZACITIDINE Alternatives Have Lower Electrocardiogram qt prolonged Risk?

AZACITIDINE vs AZATHIOPRINE AZACITIDINE vs AZD-1222 AZACITIDINE vs AZELAIC ACID AZACITIDINE vs AZELASTINE AZACITIDINE vs AZELASTINE\FLUTICASONE

Related Pages

AZACITIDINE Full Profile All Electrocardiogram qt prolonged Reports All Drugs Causing Electrocardiogram qt prolonged AZACITIDINE Demographics